Karen Lizeth Álvarez-Raigoza

Karen Lizeth Álvarez-Raigoza

Auto-generated profile, based on publicly available information

Karen Lizeth Álvarez-Raigoza

Department of Internal Medicine, Hospital Universitario San Ignacio, Bogotá, Colombia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Sage Open Medicine
Verified
Journal Article
Open access
SASandra Brigitte Amado-Garzón
Sandra Brigitte Amado-Garzón
LPLuisana Molina Pimienta
Luisana Molina Pimienta
JVJuan Manuel Vásquez-Jiménez
Juan Manuel Vásquez-Jiménez
KÁKaren Lizeth Álvarez-Raigoza
Karen Lizeth Álvarez-Raigoza
MMMauricio Manrique-Samer
Mauricio Manrique-Samer
ACAlejandra Cañas-Arboleda
Alejandra Cañas-Arboleda
Objective: The aim of this study was to evaluate survival in patients with COVID-19 and cancer, and to find factors associated with early mortality. Methods: Retrospective cohort derived from a registry of a referral center in Bogotá. Survival was analyzed according to the type of neoplasm using Kaplan–Meier method. A cox regression was performed to look for factors associated to higher risk of death. Results: Two hundred fifty-four patients were included with cancer and COVID-19, most of whom were women (median age 68 years; range 19–97). Cardiovascular comorbidities were frequent. Patients with hematologic neoplasms had higher survival than those with solid neoplasms (log-rank test, p = 0.024). C-reactive protein levels (hazard ratio 1.02; 95% confidence interval 1.00–1.03, p = 0.025), Charlson’s comorbidity index (hazard ratio 1.15; 95% confidence interval 1.06–1.26, p = 0.004) and respiratory failure (hazard ratio 4.83; 95% confidence interval 2.47–9.44, p = <0.001) were significantly associated with higher mortality. No interaction between active anticancer therapy and mortality was observed. Conclusion: In contrast to other reports, survival was worse in patients with solid tumors than in those with hematologic neoplasms. Increased C-reactive protein, Charlson’s comorbidity index and respiratory failure were associated with higher in-hospital mortality. This study reveals the complex impact of cancer and its treatment on COVID-19 outcomes, highlighting the persistent risks to cancer patients. It emphasizes monitoring C-reactive protein levels, comorbidities, and respiratory failure as key indicators of poor prognosis. Furthermore, we provide new insights into the differential impact of COVID-19 on cancer patients with solid organ versus hematologic neoplasms.

29 June 2021 in Revista Colombiana de Gastroenterología
Verified
Journal Article
Open access
PDF file
RRRómulo Darío Vargas Rubio
Rómulo Darío Vargas Rubio
OMOscar Alberto Messa
Oscar Alberto Messa
KAKaren Lizeth Alvarez
Karen Lizeth Alvarez
DMDiana Magoe Meza Madrid
Diana Magoe Meza Madrid
La úlcera rectal solitaria es una patología poco frecuente de naturaleza benigna que debe diferenciarse de otras entidades en su presentación inicial, con mecanismos fisiopatológicos definidos y con sintomatología variada. Se presenta el caso de una paciente de 31 años sin antecedentes de importancia, que consultó a nuestra institución por un cuadro de 3 años de sangrado rectal asociado con episodios de diarrea, manejada con múltiples diagnósticos.